## Note
nid: 1520730688999
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology, #AK_Step1_v11::#B&B::11_Hematology::01_Hemostasis::05_Platelet_Disorders, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Rituximab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::04_Pathology::17_Platelet_Disorders, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::04_Pathology::17_Platelet_Disorders::Immune_Thrombocytopenic_Purpura, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::23_Rituximab, #AK_Step1_v11::#OME_banner::Basic_Science::13_Hematology_Oncology::11_Hemostasis, #AK_Step1_v11::#Physeo::09_Pharm::17_Hem/Onc_Pharm::Rituximab_Bevacizumab_Alemtuzumab_Cetuximab_Panitumumab_Trastuzmab, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::02_Rituximab, #AK_Step1_v11::$AnKingUpdates::$Errata::bonus, #AK_Step1_v11::^Other::^EXPN::BGadd, #AK_Step1_v11::^Other::^FA_Updates::FA2018, #AK_Step1_v11::^Other::^HighYield::4-LowerYield, #AK_Step1_v11::^Systems::HemeOnc::Hematology
markdown: false

### Text
Initially <b>immune thrombocytopenia</b> can be treated with
steroids, but if it becomes refractory the patient can be given
{{c1::rituxi}}mab
<div>
  <i>Bonus*- what drug inhibits the macrophages?</i>
</div>

### Extra
In adults patients with persistent / chronic ITP, if side effects
for rituximab or IVig or is refractory to both; can be given
<b>fostamatinib</b> (inhibits the macrophages responsible for
clearing platelets, helping increase platelet count)

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/heme-onc/hemostasis/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_5.png"></a>
</div>

### Additional Resources


### One by one

